potassium channel kir7.1 inhibitors (University of Warwick/MRC)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namepotassium channel kir7.1 inhibitors (University of Warwick/MRC)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInward rectifier potassium channel 13 blockers
TargetsInward rectifier potassium channel 13
Therapy Area/IndicationsHemorrhageObstetric Labor, PrematureInfertility
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWarwick University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWarwick UniversityMedical Research Council
Active IndicationsN/A
Inactive IndicationsHemorrhageObstetric Labor, PrematureInfertility

Other Information

ATC CodeN/A
Related LinksN/A